S U Yasuda

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. doi request reprint The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies
    S U Yasuda
    Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
    Clin Pharmacol Ther 84:417-23. 2008
  2. doi request reprint The use of imaging in the early development of neuropharmacological drugs: a survey of approved NDAs
    R S Uppoor
    Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
    Clin Pharmacol Ther 84:69-74. 2008

Collaborators

  • S-M Huang
  • L Zhang
  • R S Uppoor
  • E Cooper
  • A G Sorensen
  • M U Mehta
  • J Collins
  • H H Pien
  • P Mummaneni

Detail Information

Publications2

  1. doi request reprint The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies
    S U Yasuda
    Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
    Clin Pharmacol Ther 84:417-23. 2008
    ..fda.gov/cder/Offices/OCPB/workshops.htm)...
  2. doi request reprint The use of imaging in the early development of neuropharmacological drugs: a survey of approved NDAs
    R S Uppoor
    Office of Clinical Pharmacology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA
    Clin Pharmacol Ther 84:69-74. 2008
    ..Imaging contributes to optimal clinical development of central nervous system (CNS)-active drugs. Opportunities are available for its broader use, contributing to improved understanding of the clinical pharmacology of CNS-active drugs...